The FK506-binding protein 51 (FKBP51) has emerged as a key regulator of endocrine stress responses in mammals and as a potential therapeutic target for stress-related disorders (depression, post-traumatic stress disorder), metabolic disorders (obesity and diabetes) and chronic pain. Recently, FKBP51 has been implicated in several cellular pathways and numerous interacting protein partners have been reported. However, no consensus on the underlying molecular mechanisms has yet emerged. Here, we review the protein interaction partners reported for FKBP51, the proposed pathways involved, their relevance to FKBP51‘s physiological function(s), the interplay with other FKBPs, and implications for the development of FKBP51-directed drugs.
CITATION STYLE
Hähle, A., Merz, S., Meyners, C., & Hausch, F. (2019, January 1). The many faces of FKBP51. Biomolecules. MDPI AG. https://doi.org/10.3390/biom9010035
Mendeley helps you to discover research relevant for your work.